Isofield

EU GMP Annex 1: Validating Sterile Facemask

Repeat Team — Thu, 14 May 2026 10:06:24 +0000

EU GMP Annex 1 Face Mask Requirements for Sterile Cleanrooms

A practical guide for procurement teams selecting sterile face masks for Grade A/B cleanrooms under EU GMP Annex 1. Learn what to validate beyond medical mask standards, including sterility validation, particle control, fit, filtration, and documentation.

Sterile manufacturing teams are under increasing pressure to justify every contamination control decision they make. Under the revised EU GMP Annex 1, that includes how operators are gowned, what risks their apparel introduces, and whether protective components such as face masks are truly suitable for aseptic environments. Annex 1 places contamination control strategy (CCS), risk management, and prevention of microbial and particulate contamination at the centre of sterile operations.

For procurement specialists, that creates a common challenge: how do you evaluate a face mask for Grade A/B use without falling into the trap of treating it like a standard medical or surgical mask purchase?

Medical face mask standards can provide useful data points, but they do not by themselves demonstrate suitability for use in a cleanroom contamination control strategy. EN 14683 is a medical face mask standard intended to limit transmission of infective agents in healthcare settings, and it explicitly is not a standard for masks intended exclusively for personal protection or a substitute for cleanroom-specific validation.

In other words, procurement for sterile cleanrooms must be driven by the CCS and the Grade A/B risk profile, not by a surgical mask datasheet alone.

Why EU GMP Annex 1 changes the procurement goalposts

EU GMP Annex 1 is not a purchasing specification, rather, a manufacturing control framework. It requires manufacturers to design and control facilities, systems, procedures, and behaviours so microbial, particulate, and endotoxin/pyrogen contamination are prevented in the final product. It also makes Quality Risk Management a minimum expectation throughout sterile manufacture.

That matters because a cleanroom face mask is not specifically PPE. In aseptic processing, it is also part of the contamination barrier between the operator and the product zone.

This is exactly the distinction your content brief highlights: PPE protects the wearer; cleanroom products protect the environment. For face masks in sterile processing, the second objective is often the more critical one.

So when procurement teams assess disposable face masks, they need to ask a stricter question:

Does this mask support contamination control in our process, or does it simply meet a healthcare product standard?

The most important mistake to avoid: sterilized is not the same as validated for sterile use

One of the biggest compliance errors is assuming that a mask is suitable for sterile use because it has been sterilized.

That is not enough.

A sterile cleanroom face mask should be supported by evidence that addresses at least three separate questions:

Was the product sterilized by a validated process?
Does the manufacturer carry the full validation documentation, dose mapping, and routine dose audits to back up these claims?
Is the product itself suitable for aseptic environments from a contamination-control perspective, including particle shedding, fit, coverage, and usability?

Annex 1 expects validated and controlled processes, not just end-state claims. It emphasizes that facility, equipment, and process controls should be designed, qualified, and validated, and that contamination risks from personnel and materials must be minimized.

For procurement, that means asking suppliers for more than a certificate that says “sterile or sterilized.” You are looking for a validation package that demonstrates:

sterilization method and validation status
sterility assurance approach and supporting documentation
packaging integrity
product suitability for the intended cleanroom grade and intervention profile
change control, traceability, and lot-level documentation where required

That aligns with your own direction to steer users toward validation evidence and interlink the validation packs page.

Medical masks vs cleanroom masks: where the standards help, and where they do not

This is the section many buyers need most.

The current EN 14683 medical mask standard covers medical face masks and their performance requirements and test methods. It includes data points such as bacterial filtration efficiency and differential pressure, and recent versions also address microbial cleanliness.

Those data points can be informative. But they should be treated as supporting characteristics, not the main compliance decision.

What medical mask data can usefully tell you

Medical face mask testing can help describe:

BFE: how the material performs against a bacterial aerosol challenge
PFE or sub-micron filtration, a useful indicator of filter-media performance where available under related medical mask frameworks
DP (differential pressure): airflow resistance, often used as a breathability indicator
microbial cleanliness / bioburden indicators: helpful but not sufficient alone, given that all Grade A/B masks should be rendered sterile. Medical / Surgical masks are not, hence the need for Bioburden reporting.

ASTM F2100 similarly classifies medical face mask material performance using BFE, differential pressure, sub-micron particulate filtration efficiency, synthetic blood penetration, and flammability, while also noting it does not address all aspects of mask design effectiveness or respiratory protection.

What medical mask data does not tell you

A surgical or medical mask test report does not automatically show:

suitability for Grade A/B aseptic operations
compatibility with your CCS
particle shedding performance in cleanroom use
full facial coverage performance in motion
sterility maintenance after sterilization and packaging
ergonomic suitability for long aseptic shifts
risk of operator adjustment during critical tasks
interaction with goggles, hoods, coveralls, and aseptic gowning systems

That is why procurement teams must not conflate medical mask, surgical mask, and cleanroom mask requirements.

What procurement teams should prioritize under EU GMP Annex 1

1) Full face coverage and containment of operator-generated contamination

A face mask used in sterile processing should help contain contamination generated from the nose, mouth, skin, and surrounding facial area.

This means procurement should look beyond a flat product photo and ask:

Does the mask provide reliable coverage over nose, mouth, cheeks, and under-chin area?
Does it stay in position during turning, speaking, bending, and prolonged wear?
Does it integrate properly with goggles, hoods, coveralls, and sterile gowning?
Does it reduce the need for readjustment, which itself introduces touch contamination risk?

For Grade A/B environments, this is not a cosmetic detail. It is part of operator contamination control.

2) Particle generation and shedding performance

Annex 1 repeatedly focuses on prevention of particulate contamination in sterile manufacture.

That means a face mask cannot be selected only for filtration efficiency. The product itself must also be assessed as a potential source of particles and fibres.

This is where cleanroom-specific evidence matters. Your brief correctly points to Helmke Drum testing as a signal of technical authority. Helmke drum methods are used to quantify particles released from garments and similar cleanroom materials during mechanical agitation, making them much more relevant to contamination control than conventional healthcare mask marketing claims.

For procurement, the practical question is:

Can the supplier show evidence that the mask material and finished construction are suitable for low-particle cleanroom use, not just that the filter media performs well in a medical test?

3) Ergonomics: ties vs earloops with clips

This is often underestimated, but it has direct compliance implications.

On paper, both ties and earloops may look acceptable. In practice, their suitability depends on the operation, shift length, and operator behaviour they drive.

Ties

typically offer more secure and customizable fit
can help maintain mask position during longer wear
may better support full-face coverage consistency
can reduce the tendency to adjust the mask during use

Earloops with clips

may be quicker to don
may improve comfort for some users
can work well in lower-risk applications
but can also create fit variability depending on head shape, hood integration, and clip tension

The right choice should be made through the CCS and operator risk assessment, not convenience alone. In Grade A/B areas, the best solution is usually the one that minimizes movement, gapping, and operator intervention.

A procurement team should therefore ask for evidence or site data on:

fit stability over time
compatibility with other sterile garments
operator comfort across shift duration
frequency of face touching or readjustment
training implications during aseptic gowning

4) Filtration performance: BFE, PFE, and what they actually mean

BFE and PFE are useful, but only when interpreted correctly.

BFE indicates filtration against bacterial aerosol challenge
PFE indicates filtration against sub-micron particulate challenge
ΔP indicates airflow resistance or breathability

These metrics can help compare products, but they are not a full cleanroom qualification package. A mask with impressive BFE or PFE may still be a poor choice for Grade A/B if it sheds particles, gaps during movement, or encourages frequent adjustment.

The right procurement approach is:

Use BFE, PFE, and ΔP as supportive data within a broader contamination-control assessment. Do not use them as stand-alone proof of Annex 1 suitability.

5) Differential pressure matters, but not in isolation

Differential pressure is often discussed as a comfort metric, and that is fair. In medical mask standards it is used as an indicator of breathability.

In sterile manufacturing, however, DP matters for a broader reason: if a mask is uncomfortable, operators are more likely to adjust it, break concentration, or wear it inconsistently. That becomes a behavioural contamination risk.

So DP should be considered in the context of:

shift duration
speaking frequency
hot or high-stress operations
compatibility with eyewear and hoods
likelihood of face touching

Again, this is why procurement must be tied back to the CCS.

6) Sterile vs non-sterile cleanroom face masks

Your brief also asks to distinguish sterile and non-sterile cleanroom face masks.

A simple way to present this:

Sterile cleanroom masks are typically appropriate where the mask enters higher-risk sterile processes, especially where aseptic interventions or Grade A/B support activities demand the strongest control over microbial introduction.

Non-sterile cleanroom masks may be appropriate in less critical controlled environments where low particle shedding and cleanroom compatibility are required, but sterility is not mandated by the process risk assessment.

The decision should be based on:

proximity to exposed sterile product
cleanroom grade
intervention type
gowning configuration
transfer and presentation controls
site CCS

What an auditor will expect procurement files to show

Whether the site is inspected by EU authorities, the MHRA, FDA, TGA, or other GMP regulators, the underlying expectation is the same: the manufacturer must be able to justify that its contamination controls are appropriate, risk-based, and evidence-backed. EMA states that any manufacturer supplying medicines to the EU market must comply with EU GMP, while MHRA and TGA both operate GMP inspection frameworks that expect compliance with sterile manufacturing controls, with TGA adopting the PIC/S GMP guide that includes Annex 1 for sterile medicinal products.

So the procurement record for a cleanroom face mask should not stop at price, lead time, or a generic declaration of conformity.

It should show, clearly:

why this product was selected for the intended grade and process
how the CCS informed the selection
what validation evidence was reviewed
what cleanroom-specific test data was considered
how sterile status and packaging integrity are assured
how ergonomics and fit reduce behavioural contamination risk
how supplier change control will be managed

The procurement standard should be “fit for aseptic use,” not “looks compliant on paper”

A medical mask may satisfy a healthcare standard.
A PPE face mask may help protect the wearer.
A surgical face mask may perform well in BFE and differential pressure tests.

But a cleanroom mask for Grade A/B procurement should be selected only when it supports the site’s contamination control strategy and can be defended during audit.

That means asking for documentation that demonstrates:

validated sterility, not just sterilization
low particle generation characteristics
reliable full-face coverage
compatibility with hoods and goggles
stable fit under real use conditions
useful filtration data interpreted in context
documentation suitable for qualification and supplier approval

If your team is reviewing sterile face coverings for Grade A/B use, the safest procurement decision is rarely the product with the simplest datasheet. It is the one backed by the strongest validation evidence, clearest contamination-control rationale, and most appropriate cleanroom performance profile.

At Isofield, that is the standard we believe procurement teams should expect from every cleanroom face mask supplier. Explore our validation packs to review the technical documentation behind our cleanroom products, and compare sterile and non-sterile options based on the criteria that actually matter in audit-ready manufacturing environments.

Quick checklist: what to ask before approving a sterile face mask supplier

Use this as a practical procurement checklist.

EU GMP Annex 1 sterile face mask checklist

Has the product been selected against the site’s CCS and Grade A/B risk profile?
Do we have evidence of validated sterility assurance, not just sterilization?
Is there documented support for packaging integrity and sterile presentation?
Does the mask provide full face coverage with stable fit during movement?
Is there evidence on particle generation / shedding, ideally from cleanroom-relevant methods such as Helmke-type testing?
Have BFE, PFE, and ΔP been reviewed as supporting data rather than sole selection criteria?
Is the fastening system, including ties or earloops with clips, appropriate for operator behaviour and aseptic gowning?
Is the product compatible with hoods, goggles, coveralls, and the wider gowning system?
Has the supplier provided adequate validation documentation, change control, and traceability?
Could we defend this selection during an FDA, MHRA, TGA, or EU GMP inspection?

EU GMP Annex 1: ‘Sterile Eye Coverings’ Explained

Repeat Team — Sun, 22 Mar 2026 08:53:02 +0000

Cleanroom goggles in EU GMP Annex 1 areas: what “sterile eye coverings” really implies (and how to qualify them)

EU GMP Annex 1 (2022) made something explicit that many facilities previously handled as “site practice”: for Grade B operations (including access/interventions into Grade A), a sterile facemask and sterile eye coverings (e.g. goggles) are expected to cover and enclose all facial skin and prevent shedding of droplets and particles.

That single line connects three things aseptic teams care about every day:

Contamination Control strategy (CCS): protecting first air and critical surfaces from people-derived droplets/particles.
Aseptic practicality: PPE must be wearable for long periods, with low fogging and strong visibility.
Qualification + lifecycle control: reusable “garments (including eye coverings)” must be managed with defined replacement frequencies, integrity checks, sterilisation assurance, and (where relevant) reprocessing cycle limits.

This post walks through goggle design options against Annex 1 expectations, then uses Isoclave IV and Isoclave CF as examples of how a reusable, autoclavable goggle can be positioned and qualified for Grade A/B sterile manufacturing.C

1) Annex 1: why eye protection becomes a CCS control point

In Grade B supporting Grade A, Annex 1 states that “a sterile facemask and sterile eye coverings (e.g. goggles) should be worn to cover and enclose all facial skin and prevent shedding of droplets and particles.”

Annex 1 also expects that where garments/eye coverings are sterilised and used aseptically, there are controls around:

Sterility status and packaging integrity
Hold times
Defined replacement frequency for reusables supported by qualification

So goggles aren’t “just PPE”. In Annex 1 terms they’re part of the barrier system around a known high-shedding zone (face/eyes)—and part of a controlled, qualified gowning system.

2) What “face coverings” generally means in sterile areas (practically)

In most Grade A/B aseptic operations, “face covering” becomes a system rather than a single item:

Mask (droplet control + facial skin coverage)
Hood/headgear (hair, facial hair, skin coverage)
Goggles / sterile eye covering (droplet/particle control; reduces face-touching risk)

Annex 1’s emphasis on enclosing facial skin is where many “good enough” options fail: open-sided eyewear and many visors reduce splash risk, but don’t reliably enclose or seal.

3) Indirect ventilation: a design feature that maps neatly to contamination control

Fogging isn’t cosmetic in aseptic processing, it’s a human factors risk (visual checks, intervention quality, and the temptation to touch/adjust PPE).

Venting helps moisture escape, but from an Annex 1 mindset you want to avoid:

Direct line-of-sight openings that can permit easier droplet/particle movement,
Turbulence/pumping effects during head movement

Indirect vent geometries aim to allow airflow exchange while reducing direct pathways. They’re not a substitute for cleanroom airflow design or technique, but they support contamination mitigation and usability at PPE level.

4) Anti-fog and anti-scratch aren’t “features”, they’re operational controls

In Grade A/B work, lens performance ties to:

Intervention quality (clear view of manipulations)
Inspection (visual checks during and after processing)
Longevity (scratches become cleaning challenges and visibility hazards)

Both Isoclave IV and Isoclave CF specify anti-fog coated lenses and premium anti-scratch performance.

5) Why “>35 autoclave cycles” matters (and what you should verify)

Steam sterilisation is attractive for reusable goggles because it is environmentally friendly, and to date market feedback has been more positive to the comfort levels vis-à-vis single use alternatives. The catch is material and coating durability.

Isoclave IV: autoclave 121°C / 30 min, lens up to 35 cycles, straps/housing up to 40 (lab conditions).
Isoclave CF: same steam parameters and cycle guidance, with a close-fit silicone housing and upper indirect vent and non-vented bottom.

What an Annex 1–aligned site does with these claims:

Treat supplier cycle data as inputs,
Confirm your own cycle definition (load configuration, packaging, drying, handling)
Set a maximum reprocessing cycle limit with defined inspection/replacement criteria

6) Worked examples: Isoclave IV vs Isoclave CF for Grade A/B use cases

Isoclave IV (indirect upper + lower ventilation)

Indirect upper and lower ventilation
Panoramic visibility
Flexible nose skirt / ergonomic frame
Anti-fog / anti-scratch optical-grade lens
Tested to EN 166 and ISO 16321-1; PPE Cat II
Supplied non-sterile; must be processed prior to aseptic use
Autoclave 121°C/30 min; lens up to 35 cycles; straps/housing up to 40 (lab conditions)

Where it tends to fit well: longer wear time, higher fog-risk tasks, operators who need moisture management and wider visibility.

Isoclave CF (close-fit, indirect top vent and non-vented bottom)

Indirect upper ventilation and non-vented bottom
Close-fit silicone housing
Clip strap fastener for easier donning
Can be worn over prescription glasses
Autoclave 121°C/30 min; lens up to 35 cycles; straps/housing up to 40 (lab conditions)

Where it tends to fit well: conservative vent preference, higher intervention frequency where stability/fit matter, and mixed user populations including prescription eyewear.

7) Alternative configurations on the market pros, cons, and typical failure modes

Option Type	Typical Strengths	Typical limitations / risks (Annex 1 lens)	Common failure modes in practice	Best-fit use cases
Single-use “sterile” goggles (EtO sterilised)	Delivered sterile; no internal reprocessing; consistent “new” optics	Potential EtO residual management expectations; lot-to-lot reliance on supplier aeration controls; waste/supply-chain dependency	Odour/irritation complaints; packaging damage; fogging variability; unclear residual documentation	High throughput, minimal reprocessing capacity, strong incoming QA controls
Single-use gamma-irradiated eyewear	Sterility without EtO aeration; simpler incoming handling. Cheaper than EtO	Polymer changes possible (optics/mechanics); shelf-life and external supplier sterility validation become critical	Yellowing/haze; brittleness; tacky feel; strap failure	Sites wanting disposable sterility with robust supplier qualification and shelf-life controls
Reusable fully sealed (non-vented) goggles	Strong enclosure; minimal openings; easier to defend as barrier	Higher fog risk; comfort/heat build-up may drive face-touching	Persistent fogging; operators adjusting; seal deformation over time	Short duration tasks; higher splash processes; controlled environments with strong anti-fog performance
Reusable indirect-vent goggles	Better fog control than sealed; can reduce direct vent pathways	Still requires CCS justification and qualification; vent design matters	Coating degradation; vent clogging (lint/particulate); inconsistent fogging after cycles	Longer wear tasks; routine aseptic operations needing visibility and comfort
Direct-vent goggles	Low fogging; inexpensive designs exist	Harder to justify as enclosure in aseptic context; direct pathways may conflict with “prevent shedding” intent	“Pumping” effect with movement; ingress/egress via vents	Lower-grade areas, non-critical tasks, splash protection (not for Grade A/B)
Safety glasses / side-shields	Comfortable; low fogging; cheap and accessible	Usually not sealed/enclosed; limited droplet/particle control around the eye region	Gaps at cheeks/temples; eyewear slipping; inadequate interface with hood/mask	Non-aseptic support zones, non-Grade A/B tasks, visitor PPE (site-dependent
Visor masks / face shields	Good splash deflection; reduces direct droplet trajectory	Typically no full seal; airflow bypass around edges	Glare; scratch; visor gap at sides/bottom; interference with hood	Supplemental protection, splash-heavy tasks, added layer over sealed eyewear (not a substitute)

8) A practical Annex 1–aligned qualification checklist for goggles (functional + documentation)

Functional / human factors

Seal/coverage: does it plausibly enclose the peri-ocular region with hood/mask interfaces?
Fog performance: worst-case wear duration, exertion, mask humidity interaction.
Optical clarity + distortion: adequate for inspection and aseptic manipulation
Stability: stays in place without frequent touching
Compatibility: prescription glasses, hood/mask, hearing protection, comms gear

Contamination control + processing

Sterility pathway defined (steam/VHP/EtO/gamma) with validation approach
For reusables: maximum cycles + replacement criteria supported by qualification
Packaging integrity checks and hold-time controls for sterilised items
Cleaning/disinfection compatibility (agents, residues, stress cracking)

Documentation / QA expectations

Supplier compliance docs (e.g., PPE standards where applicable), change notifications
Incoming inspection and lot traceability
Donning/doffing training to minimise touching outer surfaces
Deviation handling: fogging failures, lens damage, seal integrity, discard rules

9) Where Isoclave IV and CF sit in that checklist

For Annex 1 aligned Grade A/B use, Isoclave IV and Isoclave CF are positioned as reusable, autoclavable goggles with:

Indirect venting approaches (different geometries and barrier emphasis)
Anti-fog / anti-scratch lens intent
Explicit steam sterilisation conditions and cycle guidance that can be translated into a site-specific lifecycle qualification

The “right” choice is ultimately CCS driven: fog risk vs vent conservatism, stability and comfort, prescription eyewear needs, and the facility’s ability to qualify and control the reprocessing lifecycle.

Industrial Coveralls VS Cleanroom Coveralls

Repeat Team — Mon, 23 Feb 2026 02:44:58 +0000

Why Industrial Coveralls Are No Substitute for Annex 1 Grade A/B Cleanroom Coveralls

When procurement teams review consumables, single-use coveralls are an easy target for cost reduction. Industrial suits are widely available, competitively priced, and often come with impressive-looking certifications such as PPE Category III Type 5/6.

But in EU GMP Annex 1 sterile manufacturing environments, especially Grade A and B, this is exactly where a small saving can introduce a disproportionate contamination and compliance risk. The reason is simple:

Type 5/6 certification is designed to protect the wearer from chemical hazards. It does not prove the garment can support Annex 1 cleanliness or sterility expectations.

What Type 5/6 actually means (and what it doesn’t)

Industrial single-use coveralls commonly reference:

Type 5 (ISO 13982-1): requirements for clothing resistant to penetration by airborne solid particles (“dust suits”).
Type 6 (EN 13034): clothing offering limited protection against liquid chemicals (splashes/spray).

These are occupational safety standards. They are valuable, but they are not cleanroom contamination control standards.

They do not demonstrate:

low particle shedding in a cleanroom airflow regime,
retention of operator-shed particles,
cleanroom packaging and fold presentation for aseptic donning,
sterility and transfer integrity for Grade A/B,
or the garment system qualification evidence Annex 1 expects.

Annex 1 is explicit: gowning in Grade A/B must be qualified, not assumed

Annex 1 requires clean, sterile protective garments for entry to Grade B and Grade A, and it goes further by stating that garments should be selected and qualified to minimise shedding and retain particles shed by the body with particle shedding and particle retention efficiencies assessed during garment qualification. It also highlights the need for garments to be packed/folded to prevent touching the outer surface and to avoid contact with the floor during donning.

This is why, when building a Contamination Control Strategy (CCS), a validated, cleanroom-specific garment system is the only truly defensible option for Grade A/B operations.

The scientific gap: where industrial PPE suits fall short for sterile cleanrooms

Even if an industrial suit “looks clean,” the failure modes in sterile environments are predictable and they show up in EM (Environmental Monitoring) trends, investigations, and ultimately batch risk.

1) PPE certification focuses on hazard ingress, not operator emission

Type 5 testing is about preventing dust penetration into the garment for worker protection. That is not the same as controlling outward emission (particles originating from the operator) into Grade B/A environments.

In sterile manufacturing areas, the garment must function as a controlled barrier, not simply a protective suit.

That’s why pharmaceutical manufacturers typically specify validated sterile cleanroom garment systems.

2) No credible “cleanliness claim” without cleanroom-relevant test data

For Annex 1, you need evidence related to:

particle shedding (emission)
particle retention (containment)
performance as a garment system

Industrial PPE suppliers rarely provide this cleanroom-specific qualification package because it sits outside the purpose of Type 5/6 certification.

3) Packaging and aseptic usability are often overlooked, but are critical

Annex 1 expectations around pack/fold presentation exist for a reason: aseptic gowning is a high-risk step. Garments supplied without cleanroom-specific packing logic increase the chance of outer-surface contact events, floor contact, re-gowning, and deviations.

The real cost comparison: a small saving vs. a high-impact failure

The commercial risk here is asymmetric.

What procurement saves:
A few percent on a garment unit cost.

What the operation risks:

increased operator-related contamination and adverse trends,
more frequent interventions and re-gowning,
investigations that are hard to close scientifically because the garment choice lacks qualification evidence,
potential impact to sterile batches and supply continuity,
and heightened exposure during Annex 1-focused inspections.

Annex 1 also reinforces a key principle: monitoring can detect loss of control, but it does not replace robust controls by design. In Grade A/B, gowning is one of those design controls and it must stand up to scrutiny.

What to require instead: a “must-have” test data checklist (Grade A/B)

If you operate Grade A/B areas, your CCS should require that garments intended for those areas are supported by a cleanroom-relevant evidence pack. A practical minimum includes:

Cleanroom performance data

In-use particle dispersion data for the garment system (not only fabric)
Particle shedding and particle retention evidence, suitable to your grade and operations (Annex 1 expects these to be assessed during qualification)
Evidence of performance across the intended wear time (with wear time justified)

Sterile supply and handling (where required)

Stated sterilisation method and routine release controls
Packaging configuration suitable for controlled transfer (e.g., double-bag as appropriate)
Pack/fold presentation supporting aseptic donning and preventing outer-surface contact

Ongoing control essentials

Lot/batch traceability (where applicable)
Change control commitments for materials, construction, packaging, sterilisation site/process
Requalification triggers (what changes require reassessment)

The bottom line for Annex 1 environments

Industrial Type 5/6 coveralls can be excellent PPE.
But for EU GMP Annex 1 Grade A/B operations they are not a credible substitute for validated cleanroom garments, because they cannot support the cleanliness and qualification claims your CCS and your inspector will expect.

At Isofield, we help customers specify gowning systems that are appropriate for Grade A/B, supported by the right evidence, and aligned with inspection expectations not just by what’s printed on a datasheet.

If you are reviewing single-use garments for Grade A/B use, speak to Isofield about validated cleanroom garments designed to support Annex 1 compliance and CCS defensibility.

What’s the Best Glove Material for Life Science Labs?

Repeat Team — Mon, 08 Dec 2025 08:20:17 +0000

What’s the Best Glove Material for Life Science Labs: Nitrile, Latex, Vinyl, or Polychloroprene?

Selecting the right disposable glove material for a life science or pharmaceutical environment is more important than many people realise, particularly for teams working under EU GMP Annex 1 and those inspected by FDA, TGA, MHRA, KFDA, and EMA regulators. In these settings, disposable gloves are not just PPE. They are a contamination control measure, a GMP compliance requirement, and a barrier between sterile products and microbiological or particulate risk.

Whether you work in aseptic manufacturing, environmental monitoring, cell culture, QC microbiology, or cleanroom material selection, the choice between nitrile gloves, latex gloves, vinyl gloves, and polychloroprene gloves affects:

Contamination control strategy
Sterility assurance
Operator safety
Sample integrity
Audit defensibility
Compatibility with disinfectants, sterilants, and glove change protocols

A glove that performs well in a clinical setting may fail in a Grade A or B cleanroom. Likewise, a glove chosen for comfort may degrade when exposed to IPA, hydrogen peroxide, hypochlorite, or rotational QUAT disinfectants. This guide frames glove material selection within GMP expectations and contamination control strategy principles, helping you choose the right glove substrate for your workflow and for regulatory scrutiny.

What Do Life Science Labs Really Need?

Regulated life science environments expect gloves to deliver:

High chemical and disinfectant resistance
Gloves must tolerate sterilant rotation programs that include IPA, hydrogen peroxide, chlorine agents, and QUATs.

Strong puncture protection
Important for microbiologists and aseptic operators handling stainless steel tools, EM plates, sampling devices, and filtration assemblies.

Low particulate shedding and minimal contamination
Essential for aseptic processing, isolators, RABS, and any open-door intervention.

Reduced allergenic risk
Facilities must protect operators while avoiding avoidable allergen introduction.

Reliable tactile sensitivity
Critical for aseptic manipulations, pipetting, EM sampling, and microbiology techniques.

Different glove materials offer different advantages and limitations, which is why material selection must be deliberate and risk based.

Nitrile Gloves. The All Rounder for GMP Environments

Strength and Durability

Nitrile gloves provide excellent puncture resistance and mechanical strength. They are ideal for aseptic setups, environmental monitoring, microbiology, and high frequency glove change workflows.

Chemical Resistance

Nitrile gloves offer leading protection against solvents, disinfectants, sterilants, chemotherapy and laboratory reagents. They generally maintain integrity under QUAT, chlorine, peroxide, and IPA exposure, making them suitable for GMP cleanrooms.

Hypoallergenic Benefits

Nitrile gloves are latex free gloves, which helps prevent Type I latex allergy reactions and supports safe multi operator environments.

Comfort and Fit

Modern nitrile designs are flexible and comfortable while maintaining strong grip and tactile sensitivity.

Shelf Life and Supply Security

Compared to latex gloves, nitrile gloves typically offer longer and more stable shelf life, which supports GMP validated material management and audit ready traceability.

➡ See our nitrile gloves.

Latex Gloves. Comfort with Limitations

Exceptional Comfort

Latex gloves deliver outstanding elasticity and tactile precision. They remain popular for non-chemical tasks that require fine motor control.

Allergy Considerations

Latex proteins introduce allergy risk, which is a major concern in multiuser environments and a key reason many GMP facilities transition to latex free gloves. However, it is important to check with the manufacturer before making a final decision. Premium cleanroom grade latex gloves undergo extensive processing to remove residual proteins and are routinely tested with documented protein level reporting. These enhanced specifications help ensure that users are not exposed to levels above recommended thresholds. Facilities considering latex gloves for specialist tasks should confirm protein specifications, validation data, and compliance certificates before approving the material for GMP use.

Chemical Limitations

Latex gloves are less resistant to solvents, oils, and disinfectants. Prolonged exposure to IPA or sterilants can cause degradation, making latex gloves unsuitable for most aseptic and cleanroom operations.

➡Explore our latex gloves.

Vinyl Gloves. Cost Effective For Light, Non GMP Tasks

What They Are

Vinyl gloves are made from PVC and are inexpensive and latex free.

Ideal Use Cases

Suitable for short, low risk tasks such as basic cleaning, non-hazardous handling, and support activities outside the GMP core.

Limitations

Vinyl gloves offer limited durability, limited chemical resistance, and lower tactile acuity. They are not suitable for aseptic processing, microbiology workflows, or cleanroom environments.

Polychloroprene (Neoprene) Gloves. A High Comfort, High Chemical Resistance Alternative

Polychloroprene gloves, commonly known as neoprene gloves, are synthetic rubber gloves that offer a balance between latex like comfort and nitrile like chemical resistance. They are increasingly used in life science settings where tactile sensitivity and disinfectant compatibility are both required.

Why They Matter in GMP Environments

Excellent resistance to alcohols, disinfectants, and many sterilant chemistries
High elasticity with comfortable stretch like latex gloves
Reliable performance during repetitive sanitisation
Better durability than vinyl gloves and competitive performance with nitrile gloves

They are valued by aseptic operators who require comfort during extended periods in isolators or RABS while maintaining compliance with Annex 1 contamination control expectations.

Allergen and Sensitivity Benefits

Neoprene gloves are latex free, which makes them suitable for facilities reducing allergenic materials in their PPE portfolio.

Where They Fit Best?

Neoprene gloves work well for:

Aseptic filling
Cell culture operations
Environmental monitoring
QC microbiology
Cleanroom sampling
Long duration manipulations

➡ Explore our polychloroprene gloves

Which glove is best for Life science Labs?

In regulated laboratories and cleanrooms, nitrile gloves are the most broadly suitable choice, offering excellent chemical resistance, strong mechanical protection, and latex free composition.

Latex gloves offer maximum dexterity but require strict allergen control.Vinyl gloves are only appropriate for low risk, non GMP workflows. Polychloroprene gloves provide a strong balance of comfort, flexibility, and disinfectant compatibility, making them an appealing option for long duration aseptic tasks, where budgets allow.

If your facility wants to standardise materials across operations, Isofield can support risk assessments and URS creation.

Practical tips for choosing gloves

Assess chemical, biological, and mechanical risks based on your CCS
Use nitrile gloves for chemical handling, aseptic operations, and disinfectant heavy workflows
Use vinyl gloves for low risk and short duration tasks
Consider polychloroprene gloves when operator comfort and dexterity are needed without compromising disinfectant compatibility
Ensure gloves meet EN ISO and ASTM standards
Validate glove change and sanitisation procedures
Train operators in correct donning and doffing practices

For workflow specific or audit driven glove selection guidance, our team can help. Contact us.

Most labs choose nitrile but Neoprene is rising

Nitrile gloves provide the most complete package of protection, comfort, and regulatory compatibility. Latex gloves remain a good option for operators prioritising dexterity, and vinyl gloves fill a budget conscious role in non-regulated areas. Neoprene gloves are becoming increasingly popular for aseptic and cleanroom operators who require comfort during long wear times and reliable compatibility with disinfectant rotation cycles.

➡ Explore Isofield’s full glove range to equip your team with validated, high-performance protection.

Choosing Sterile Gloves for EU GMP Annex 1 Cleanrooms: A Practical Guide

Kanya — Thu, 27 Nov 2025 06:44:30 +0000

This guide is engineered for Pharmaceutical manufacturers operating under EU GMP Annex 1. It explains how to select, validate, qualify, and routinely manage sterile gloves for Grade A/B/C/D environments with concrete, inspection-ready details. Use it as a specification template, training aid, and procurement playbook.

1) Executive summary (what to choose, fast)

Use disposable sterile gloves validated to a sterility assurance level (SAL) of 10^-6 (e.g., gamma-irradiated).
Material: cleanroom nitrile (low particulates/extractables); low protein sterile latex gloves where tactile acuity is critical and allergy risk is managed; avoid vinyl in Grades A/B.
AQL <= 0.65 for pinholes (Type I defects).
Endotoxin limit: target <= 20 EU/pair for aseptic processing.
Particle/ionic cleanliness: certified per lot with Certificate of Analysis (COA).
Length: 300–400 mm with beaded cuffs; use 400 mm+ where gown overlap is marginal.
Surface: textured/micro-roughened for IPA / Ethanol handling.
Packaging: pair-packed, walleted, sterile with lot-level irradiation and sterility certificates as
well as validation; designed for aseptic transfer.
Double-don protocol with sterile 70% IPA in-use disinfection at validated frequencies.

For Grades C/D, sterile gloves may still be required when handling sterilised components or high-risk operations; otherwise, non-sterile gloves may be acceptable where justified by risk assessment and SOPs.

2) What Annex 1 expects (and where gloves fit)

Grades A/B: Sterile gloves are mandatory; regularly disinfect during operations and replace when compromised.
Routine verification: Gloved fingertip sampling (pre/post) during media fills and routine monitoring; trend and act on recoveries.
Isolators/RABS: Use sterile, validated gloves/gauntlets; perform integrity testing at defined intervals and after interventions.
Training & qualification: Operators trained and periodically qualified in gowning and glove sanitization technique, including validated in-use disinfection.

Audit-ready tip: Map each Annex 1 clause related to gowning/gloving into your CCS and link to SOPs for selection, receipt, quarantine, release, in-use disinfection, replacement, EM, and deviations.

3) Materials comparison: sterile latex gloves vs nitrile vs vinyl

Type	Material	Barrier & durability	Chemical compatibility	Tactile sensitivity	Allergen risk	Typical use case
Sterile latex gloves	Natural rubber latex	Excellent elasticity; conforms to fingers	Moderate; avoid strong ketones/aromatics	Highest tactile acuity	Allergy risk (Type I)	Precision aseptic assembly
Sterile nitrile gloves	Synthetic nitrile rubber	High puncture/tear resistance; robust in wet IPA	Good vs many solvents, acids, chemotherapy agents, bases	Very good (slightly less than latex)	Latex-free (Type I & IV), if accelerator-free	Default for high-throughput aseptic lines
Sterile vinyl gloves	PVC	Lowest durability; higher tear risk	Poor–moderate; plasticizer migration risk	Low–moderate	Latex-free	Short tasks in Grades C/D; avoid for Grades A/B

Recommendation: In Annex 1 aseptic areas, favour sterile nitrile for the best overall balance; deploy sterile latex gloves for ultra-precision tasks when allergies are managed; generally avoid vinyl for critical aseptic operations.

4) Sterility & cleanliness specs to put in your URS

Include the following in your User Requirements Specification (URS) for disposable sterile
gloves:

1. Sterility: Gamma irradiation (ISO 11137) validated to SAL 10^-6 provide lot-level Certificate of Sterility and routine dose audit reports.

2. Bioburden & Endotoxin: Pre-sterilisation bioburden limits trended (ISO 11737). Endotoxin 20 EU/pair.

3. Particulate & chemical reporting: Cleanroom-compatible processing/packaging; certificates for NVR/ions; silicone-free options if needed.

4. Physical quality: AQL <= 0.65 for pinholes; tensile strength/elongation per EN/ASTM; powder-free.

5. Design: Length minimum 300–400+ mm; beaded cuffs; ambidextrous or hand-specific; textured fingertips or full-palm texture; high-contrast color for breach detection where appropriate.

6. Packaging & labelling: Cleanroom HDPE, Easy Tear preferred over Peel Pouch, Pair-packed, walleted, double/triple-bagged for unidirectional transfer; clear lot/expiry, irradiation indicator, storage conditions.

7. Documentation: COA/COC/COP per lot (sterility, endotoxin, AQL, particulate); change control notifications; shelf-life and stability data.

5) Double-don strategy & in-use disinfection (with examples)

8. Don gown per SOP; sanitize hands.

9. Don inner sterile glove (e.g., Green).

10. Apply sterile 70% IPA (contact time per label) without over-wetting seams.

11. Don outer sterile glove (e.g., White).

12. Disinfect outer gloves at defined frequency: at entry to Grade B/A, before critical manipulations, after touching non-product-contact surfaces, and every 15–30 minutes (as validated).

13. Replace outer glove if torn/soiled or after defined maximum wear time (e.g., 2–4 hours); replace inner glove per shift or upon compromise.

Isolators/RABS: Define gauntlet maximum use time and integrity test

6) Choosing between sterile nitrile vs sterile latex in Annex 1 operations

Frequent solvent/IPA handling, opt for sterile nitrile.
Microsurgical dexterity needed opt for Consider sterile latex gloves; manage allergy risk, check protein reporting.
High tear/puncture risk opt for Sterile nitrile cuff at 0.10-0.12 mm with textured palm and or fingers.
Extended wear/perspiration opt for Low-modulus sterile nitrile. Avoid inner coatings due to particulation risk.

7) Thickness, cuff length, and texture—how to specify

Thickness: 0.10 mm for tactile acuity; 0.12+ mm for durability.
Cuff length: Minimum 300mm; increasingly 400mm preferred by external auditors where sleeve overlap risk exists.
Texture: Fingertip texture for instruments; full-palm texture for vial/stopper grip in wet IPA.

8) Cleanroom grades and glove policy examples

Grade A: Cleanroom Sterile gloves mandatory; double-don; frequent disinfection; immediate change on compromise; fingertip monitoring per batch/shift.
Grade B: Cleanroom Sterile gloves; routine disinfection; time/event-based changes.
Grades C/D: Risk-based. Cleanroom Sterile gloves when handling sterilized components or open product-contact parts; otherwise high-quality non-sterile gloves acceptable per CCS and SOPs.

9) Compliance pack: what your QA will ask for

Validation packs (full product data, design, testing, packaging)
Vendor Quality Agreement (sterilization, change control, notifications).
Lot CoA/CoC: sterility/SAL, AQL, particulate/endotoxin, physical properties.
Irradiation validation summary and dose audits.
Shelf-life and packaging integrity studies; transit/shipping validation.
Allergen labeling and latex-free statements where applicable.
REACH, Prop 65 ROHS and extractables/leachables statements upon request.

10) Frequently asked questions

Q: Are non-sterile gloves acceptable in any Annex 1 area?

A: In Grades C/D, yes—if risk assessment shows no impact on product sterility and no exposed sterilized parts are handled. In Grades A/B, use sterile gloves.

Q: What AQL should we specify?

A: For aseptic operations, ≤ 0.65 is commonly specified to minimize breach risk; align with risk tolerance and validation data.

Q: Latex vs nitrile for aseptic assembly?

A: If maximum tactile acuity is critical and no latex sensitivity exists, sterile latex gloves perform well. Otherwise, sterile nitrile provides a strong balance with IPA compatibility.

Q: How often should we disinfect gloves?

A: Define frequencies via SOPs (e.g., entry to higher grade, before critical tasks, after touching non-critical surfaces, every 15–30 minutes) and verify via EM trends and media fills.

Q: What about EtO-sterilized gloves?

A: Unacceptable even if vendor meets ISO 11135/10993-7 and provides residual data. EtO implies paper packaging due to sterilization modality, and no paper packaging should be in A/B, C or D environments.

11) Selection matrix and URS template

Process scenario	Recommended glove	Notes
Aseptic filling (wet IPA, stoppering)	Sterile nitrile, textured, cuff 0.10–0.12 mm, 400 mm	Double-don; disinfect frequently
Aseptic micro-assembly	Sterile latex gloves, textured fingertips, 0.10 mm	Confirm no latex sensitivity; monitor fingertip EM
Component prep in Grade B	Sterile nitrile, 300 mm	Outer glove changes at defined intervals
Grades C/D equipment handling	High-quality non-sterile gloves (nitrile), 300 mm	Sterile when handling sterilized parts
Isolator/RABS gauntlet use	Validated sterile gauntlets + disposable sterile gloves (outer layer)	Integrity test gauntlets; event/time-based outer-glove changes

URS excerpt you can paste into procurement brief:

Disposable sterile gloves, SAL 10^-6 (gamma preferred), AQL <= 0.65, endotoxin <= 20 EU/pair.
Material: nitrile (primary); latex option for precision tasks; vinyl excluded for Grades A/B.
Powder-free, low NVR/ions; pair-packed, walleted, double-bagged.
Length >= 300 mm (>= 400 mm where indicated); textured fingertips/palm.
Lot documentation: CoA (sterility, AQL, endotoxin, particulate), irradiation certificate, expiry, storage.
Standards: ISO 11137/11135/10993-7, ISO 11737, EN 455/ISO 21420, EN ISO 374 (where applicable).
Supplier QA: change control, CoA availability within 24 h, annual review meeting.

12) Common pitfalls and how to avoid them

Specifying only “sterile gloves” without AQL/endotoxin/cleanliness criteria. Request Sterile Cleanroom Gloves.
Single-don policy in aseptic filling instead of double-don with contrasting colors.
Ignoring cuff length leading to wrist/forearm exposure during reach-in tasks.
Unvalidated disinfection frequency (too infrequent or excessive).
Latex sensitivity not managed with alternatives and surveillance.
Mixing brands/lots within a shift complicating deviations and trending.

13) How Isofield helps (and what to ask us for)

Isofield — Leading Manufacturer of Sterile Gloves

Disposable sterile gloves with SAL 10^-6, AQL <= 0.65, low endotoxin, and cleanroom-ready pair-packed, walleted, double-bagged presentation.
Options: sterile nitrile (standard and high-dexterity, white and Green for color contrast), sterile latex gloves for precision tasks, and controlled non-sterile gloves for Grades C/D per risk assessment.
Full lot traceability and CoA delivery with each shipment.

Evaluation support: Request our free sample kit (nitrile + latex variants, 300/400 mm, textured options). Our technical team will help align SOPs for double-don and in-use disinfection to Annex 1 expectations.

14) Glossary (quick refresher for QA and Operators)

AQL: Acceptance Quality Limit; lower value = tighter pinhole control.

CCS: Contamination Control Strategy; site-wide plan integrating gowning/gloving controls.

Endotoxin: Pyrogenic LPS; gloves for aseptic work should have low EU/pair levels.

IPA: Isopropyl alcohol; generally use 70/30 sterile product for glove disinfection.

SAL: Sterility Assurance Level; probability of a non-sterile unit (10^-6 for terminal sterilization).

URS: User Requirements Specification; your technical purchase spec.

Four quick and crucial facts about cleanrooms

Kanya — Tue, 18 Nov 2025 04:36:46 +0000

1. What is a cleanroom?

According to the ISO14644-1 (International Standards Organisation), a cleanroom is a room where the number of airborne particles is controlled and classified and which is designed, constructed and operated in a manner to control the introduction, generation and retention of particles inside the room.[1] In other words, cleanrooms are rooms in which environments are controlled for critical activities.

2. How to determine cleanroom class?

Cleanroom classes are categorized by the number of airborne particles allowed in each room. The less airborne particles present, the cleaner the room. Levels of cleanroom are expressed in terms of an ISO Class, which represents maximum allowable concentrations of particles in a unit volume of air. ^[1]

Table 1 – ISO Classes of air cleanliness by particle concentration

a. All concentrations in the table are cumulative. e.g. for ISO Class 5, the 10,200 particles shown at 0.3 µm include all particles equal to and greater than this size.

b. These concentrations will lead to large air sample volumes for classification. A sequential sampling procedure may be applied; (see [1] page 33).

c. Concentration limits are not applicable in this region of the table due to very high particle concentration.

d. Sampling and statistical limitations for particles in low concentrations make classification inappropriate.

e. Sample collection limitations for both particles in low concentrations and sizes greater than 1 µm make classification at this particle size inappropriate, due to potential particle losses in the sampling system.

f. In order to specify this particle size in association with ISO Class 5, the macroparticle descriptor M may be adapted and used in conjunction with at least one other particle size. (see [1] page 26)

g. This class is only applicable for the in-operation state.

3. What is a cleanroom used for?

Cleanroom environments are highly controlled. The main function of these extremely clean areas is to help manage and mitigate particle contamination generated by people, products and processes. In Life Sciences, cleanrooms are used to produce injectables like vaccines, ingestible like tablets as well as implantable like pacemakers. In short, industries which make pharmaceuticals, medical devices and other biotech products will use a cleanroom as a critical component in their day-to-day working environment.

4. How to control contamination in a cleanroom?

Humans are by far the biggest source of contamination in any cleanroom. Our every movement generates particles. The goal is to always ensure that we do not unnecessarily introduce particles into a cleanroom environment. A large part in controlling particles in environments is through the proper selection of consumables used by personnel working in the cleanroom. Every piece of PPE (Personal Protective Equipment) used must be selected to ensure it minimises the ingress of particles into the Cleanroom. In fact, the EU GMP Annex 1: Manufacture of Sterile Medicinal Products outlines the criteria necessary for the consideration and selection of Cleanroom PPE depending on the classification of the environment [1]

Isofield’s range of PPE consumables are compatible for both ISO Class 4 or ISO Class 5 cleanrooms. Technical reports are available to confirm the cleanliness of our products and are available upon request.

References

[1] “Cleanrooms and associated controlled environments – Part 1: Classification of air cleanliness by particle concentration.” <https://zoser.com.co/wp-content/uploads/2015/10/ISO%2014644-1%20Version%202015.pdf> Accessed July 2, 2021

Five techniques to maintain sterility: FDA Guidance

Kanya — Tue, 18 Nov 2025 04:03:47 +0000

STERILE DRUG PRODUCTS PRODUCED BY ASEPTIC PROCESSING —CURRENT GOOD MANUFACTURING PRACTICE

The FDA guide is intended to help manufacturers meet the requirements in the Agency’s Current Good Manufacturing Practice (CGMP) regulations (2l CFR parts 210 and 211) when manufacturing sterile drug and biological products using aseptic processing.

1. Contact sterile materials only with sterile instruments

Sterile cleanroom gloves should be regularly sanitized or changed, as appropriate, to minimize the risk of contamination after initial gowning to minimize contamination risks.

2. Move slowly and deliberately

Rapid movements can create an unacceptable turbulence in a critical area. Such movements can present challenges to the intended cleanroom design and control parameters that needs to be maintained while housing sterile products. The principle of slow, careful movement should be followed throughout the cleanroom.

3. Keep the entire body out of the path of unidirectional airflow

Unidirectional airflow design is used to protect sterile equipment surfaces, container closures and product. Disruption of the path of unidirectional flow air in the critical area can pose a risk to product sterility.

4. Approach a necessary manipulation in a manner that does not compromise sterility of the product

To maintain sterility of nearby sterile materials, a proper aseptic manipulation should be approached from the side and not from above the product (in vertical unidirectional flow operations). Also, operators should refrain from speaking when in direct proximity of the critical area.

5. Maintain proper gown control

Prior to and throughout aseptic operations, an operator should not engage in any activity that poses an unreasonable contamination risk to the gown. The gown should provide a barrier between the body and exposed sterilized materials and prevent contamination from particles generated by, and microorganisms shed from, the body.

The Agency recommends gowns that are sterilized and non-shedding, and covering the skin and hair (face-masks, hoods, beard/moustache covers, protective goggles, and elastic gloves are examples of common accessories to gowns). Written procedures should detail the methods used to don the gown and each of the accessories in an aseptic manner. An adequate barrier should be created by the overlapping of gown and accessories (e.g., gloves overlapping sleeves). Gloves should also be sanitized regularly.

*Content has been adapted from the FDA Guidance Document. Original document here: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/sterile-drug-products-produced-aseptic-processing-current-good-manufacturing-practice

Considerations in selecting arm protection for vaccine manufacturing

Kanya — Tue, 18 Nov 2025 03:35:16 +0000

Vaccine production dates back to the 1700’s. Today thankfully, vaccines are commonplace and highly effective. With the recent SARS-CoV-2 outbreak, many have benefited directly from this life-saving technology.

Vaccine production can present serious risks to patients if not managed carefully. The manufacture of vaccines and similar biologics are carried out in ISO Class 5, Grade A environments. This means that not only must the area be mostly free of particles, but also effectively sterile. Constant vigilance and process control is critical as contaminants can still be introduced into these cleanrooms, usually coming from bulk material and equipment, but primarily from cleanroom operators. (1)

Below are the considerations to make when selecting gloves for vaccine manufacturing:

Length of gloves

300mm (12”) length gloves still remain the most widely used length of gloves in sterile environments today. The trend, however, is shifting to a 400mm (16”) length glove. Many regulatory agencies stress the need to provide adequate forearm coverage by properly overlapping gloves on the gown sleeves. A 400mm (16”) glove ensures that the entire forearm is covered thereby reducing the risk of skin exposure. A longer length, depending on material and thickness, may also provide protection to operators who work with harmful chemicals or pathogenic strains.

Double gloving

Smooth inner glove
If you are double gloving, you need to ensure that the 1st pair (inner pair) of gloves you put on has a smooth outer surface to aid the donning of the 2nd glove on top.

Length of inner glove and outer glove
A 300mm (12”) glove is commonly used as the inner glove while a 400mm (16”) glove is used as the outer glove to provide maximum coverage. In many instances end users may also choose a 400mm (16”) inner glove as well as a 400mm (16”) outer glove.

Sterility of gloves
This decision depends on each company’s SOP. Some companies will have a protocol which mandates a non-sterile inner glove (sanitized with some form of alcohol or sporicidal biocide), with a sterile glove on top, or simply one sterile glove on top of another sterile glove.

Colour

Using contrasting inner and outer gloves helps operators to visually detect punctures or tears triggering an immediate glove change to avoid any contamination risk.

GLOVE polymer coating

It is imperative to ensure that gloves selected for vaccine manufacturing are not polymer coated. Polymer coated gloves will generate particles contributing to process contamination when used. Opt for gloves from your suppliers that have been chemically treated to make them smooth and powder-free as this process leaves no residues or loose particles which can be introduced into your cleanroom.

Also important: sterility

As vaccine manufacturers, it is critical to validate the sterility of the gloves which you have received from your suppliers. Request from them documents which prove the sterility of the product, in particular the sterility validation file. Ensure that suppliers are also able to provide routine dose audit documents for the gloves to ensure the glove you are using are still appropriate regardless of the regularity of their production (2)

Isofield manufactures 600mm (24″),400mm (16″) and 300mm (12″) sterile gloves which are suitable for use in aseptic / sterile environments (Grade A/ISO Class 5). We can guide you in the selection of the suitable hand and arm protection after considering your processes and systems. Get in touch with us to find the right gloves for your vaccine manufacturing.

References

“Environmental Monitoring of Clean Rooms in Vaccine Manufacturing Facilities: Points to consider for manufacturers of human vaccines.” <https://dcvmn.org/wp-content/uploads/2016/03/who_env_monitoring_cleanrooms_final_2_.pdf>. Accessed July 5, 2021.
“Method 1 Quarterly Dose Audits: Interpretation Of Results” <https://www.steris-ast.com/techtip/method-1-quarterly-dose-audits-interpretation-results/ >. Accessed July 5, 2021